Branded medicines face new NHS cost controls

Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.